Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

446 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial.
Brown JP, Prince RL, Deal C, Recker RR, Kiel DP, de Gregorio LH, Hadji P, Hofbauer LC, Alvaro-Gracia JM, Wang H, Austin M, Wagman RB, Newmark R, Libanati C, San Martin J, Bone HG. Brown JP, et al. Among authors: hofbauer lc. J Bone Miner Res. 2009 Jan;24(1):153-61. doi: 10.1359/jbmr.0809010. J Bone Miner Res. 2009. PMID: 18767928 Free article. Clinical Trial.
Novel therapies in benign and malignant bone diseases.
Rachner TD, Hadji P, Hofbauer LC. Rachner TD, et al. Among authors: hofbauer lc. Pharmacol Ther. 2012 Jun;134(3):338-44. doi: 10.1016/j.pharmthera.2012.02.005. Epub 2012 Feb 28. Pharmacol Ther. 2012. PMID: 22401778 Review.
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.
Roux C, Hofbauer LC, Ho PR, Wark JD, Zillikens MC, Fahrleitner-Pammer A, Hawkins F, Micaelo M, Minisola S, Papaioannou N, Stone M, Ferreira I, Siddhanti S, Wagman RB, Brown JP. Roux C, et al. Among authors: hofbauer lc. Bone. 2014 Jan;58:48-54. doi: 10.1016/j.bone.2013.10.006. Epub 2013 Oct 17. Bone. 2014. PMID: 24141036 Free article. Clinical Trial.
[The experiences are uniformly very good].
Hofbauer L, Hadji P. Hofbauer L, et al. MMW Fortschr Med. 2015 Jul 23;157(13):87. doi: 10.1007/s15006-015-3322-9. MMW Fortschr Med. 2015. PMID: 26206010 German. No abstract available.
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab.
Hadji P, Kyvernitakis I, Kann PH, Niedhart C, Hofbauer LC, Schwarz H, Kurth AA, Thomasius F, Schulte M, Intorcia M, Psachoulia E, Schmid T. Hadji P, et al. Among authors: hofbauer lc. Osteoporos Int. 2016 Oct;27(10):2967-78. doi: 10.1007/s00198-016-3623-6. Epub 2016 May 12. Osteoporos Int. 2016. PMID: 27172934 Free PMC article.
Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CA, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A. Cosman F, et al. Among authors: hofbauer lc. N Engl J Med. 2016 Oct 20;375(16):1532-1543. doi: 10.1056/NEJMoa1607948. Epub 2016 Sep 18. N Engl J Med. 2016. PMID: 27641143 Free article. Clinical Trial.
Bone health during endocrine therapy for cancer.
Rachner TD, Coleman R, Hadji P, Hofbauer LC. Rachner TD, et al. Among authors: hofbauer lc. Lancet Diabetes Endocrinol. 2018 Nov;6(11):901-910. doi: 10.1016/S2213-8587(18)30047-0. Epub 2018 Mar 20. Lancet Diabetes Endocrinol. 2018. PMID: 29572126 Review.
446 results